This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2009 Sep 17;361(12):1202-5.

doi: 10.1056/NEJMe0906092. Epub 2009 Sep 2.

Following the hedgehog to new cancer therapies

Andrzej A Dlugosz, Moshe Talpaz

PMID: 19726764
DOI: 10.1056/NEJMe0906092

Editorial

Following the hedgehog to new cancer therapies

Andrzej A Dlugosz et al. N Engl J Med. 2009.

. 2009 Sep 17;361(12):1202-5.

doi: 10.1056/NEJMe0906092. Epub 2009 Sep 2.

Authors

Andrzej A Dlugosz, Moshe Talpaz

PMID: 19726764
DOI: 10.1056/NEJMe0906092

No abstract available

PubMed Disclaimer

Comment on

Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449.
Rudin CM, Hann CL, Laterra J, Yauch RL, Callahan CA, Fu L, Holcomb T, Stinson J, Gould SE, Coleman B, LoRusso PM, Von Hoff DD, de Sauvage FJ, Low JA. Rudin CM, et al. N Engl J Med. 2009 Sep 17;361(12):1173-8. doi: 10.1056/NEJMoa0902903. Epub 2009 Sep 2. N Engl J Med. 2009. PMID: 19726761 Free PMC article.
Inhibition of the hedgehog pathway in advanced basal-cell carcinoma.
Von Hoff DD, LoRusso PM, Rudin CM, Reddy JC, Yauch RL, Tibes R, Weiss GJ, Borad MJ, Hann CL, Brahmer JR, Mackey HM, Lum BL, Darbonne WC, Marsters JC Jr, de Sauvage FJ, Low JA. Von Hoff DD, et al. N Engl J Med. 2009 Sep 17;361(12):1164-72. doi: 10.1056/NEJMoa0905360. Epub 2009 Sep 2. N Engl J Med. 2009. PMID: 19726763 Clinical Trial.

Similar articles

Harnessing hedgehog for the treatment of basal cell carcinoma.
Harms KL, Dlugosz AA. Harms KL, et al. JAMA Dermatol. 2013 May;149(5):607-8. doi: 10.1001/jamadermatol.2013.448. JAMA Dermatol. 2013. PMID: 23677088 No abstract available.
Inhibition of the hedgehog pathway in advanced basal-cell carcinoma.
Von Hoff DD, LoRusso PM, Rudin CM, Reddy JC, Yauch RL, Tibes R, Weiss GJ, Borad MJ, Hann CL, Brahmer JR, Mackey HM, Lum BL, Darbonne WC, Marsters JC Jr, de Sauvage FJ, Low JA. Von Hoff DD, et al. N Engl J Med. 2009 Sep 17;361(12):1164-72. doi: 10.1056/NEJMoa0905360. Epub 2009 Sep 2. N Engl J Med. 2009. PMID: 19726763 Clinical Trial.
Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449.
Rudin CM, Hann CL, Laterra J, Yauch RL, Callahan CA, Fu L, Holcomb T, Stinson J, Gould SE, Coleman B, LoRusso PM, Von Hoff DD, de Sauvage FJ, Low JA. Rudin CM, et al. N Engl J Med. 2009 Sep 17;361(12):1173-8. doi: 10.1056/NEJMoa0902903. Epub 2009 Sep 2. N Engl J Med. 2009. PMID: 19726761 Free PMC article.
Hedgehog signaling in basal cell carcinoma.
Otsuka A, Levesque MP, Dummer R, Kabashima K. Otsuka A, et al. J Dermatol Sci. 2015 May;78(2):95-100. doi: 10.1016/j.jdermsci.2015.02.007. Epub 2015 Feb 23. J Dermatol Sci. 2015. PMID: 25766766 Review.
Clinical implications of hedgehog signaling pathway inhibitors.
Liu H, Gu D, Xie J. Liu H, et al. Chin J Cancer. 2011 Jan;30(1):13-26. doi: 10.5732/cjc.010.10540. Chin J Cancer. 2011. PMID: 21192841 Free PMC article. Review.

See all similar articles

Cited by

Structure of Sonic Hedgehog protein in complex with zinc(II) and magnesium(II) reveals ion-coordination plasticity relevant to peptide drug design.
Bonn-Breach R, Gu Y, Jenkins J, Fasan R, Wedekind J. Bonn-Breach R, et al. Acta Crystallogr D Struct Biol. 2019 Nov 1;75(Pt 11):969-979. doi: 10.1107/S2059798319012890. Epub 2019 Oct 30. Acta Crystallogr D Struct Biol. 2019. PMID: 31692471 Free PMC article.
Tamoxifen Resistance: Emerging Molecular Targets.
Rondón-Lagos M, Villegas VE, Rangel N, Sánchez MC, Zaphiropoulos PG. Rondón-Lagos M, et al. Int J Mol Sci. 2016 Aug 19;17(8):1357. doi: 10.3390/ijms17081357. Int J Mol Sci. 2016. PMID: 27548161 Free PMC article. Review.
SHH desmoplastic/nodular medulloblastoma and Gorlin syndrome in the setting of Down syndrome: case report, molecular profiling, and review of the literature.
Mangum R, Varga E, Boué DR, Capper D, Benesch M, Leonard J, Osorio DS, Pierson CR, Zumberge N, Sahm F, Schrimpf D, Pfister SM, Finlay JL. Mangum R, et al. Childs Nerv Syst. 2016 Dec;32(12):2439-2446. doi: 10.1007/s00381-016-3185-0. Epub 2016 Jul 21. Childs Nerv Syst. 2016. PMID: 27444290 Review.
Shh and p50/Bcl3 signaling crosstalk drives pathogenesis of BCCs in Gorlin syndrome.
Chaudhary SC, Tang X, Arumugam A, Li C, Srivastava RK, Weng Z, Xu J, Zhang X, Kim AL, McKay K, Elmets CA, Kopelovich L, Bickers DR, Athar M. Chaudhary SC, et al. Oncotarget. 2015 Nov 3;6(34):36789-814. doi: 10.18632/oncotarget.5103. Oncotarget. 2015. PMID: 26413810 Free PMC article.
Merkel Cell Carcinoma with a Suppressor of Fused (SUFU) Mutation: Case Report and Potential Therapeutic Implications.
Cohen PR, Kurzrock R. Cohen PR, et al. Dermatol Ther (Heidelb). 2015 Jun;5(2):129-43. doi: 10.1007/s13555-015-0074-5. Epub 2015 Apr 15. Dermatol Ther (Heidelb). 2015. PMID: 25876211 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

R01 CA087837/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database